Reply to “A better interpretation of data regarding the opioid switching to methadone”

In our article ?Methadone switching for refractory cancer pain’ (BMC palliative care, 2022) we explore the efficacy, safety and economics of methadone in treatment of patients with refractory cancer pain in China. Professor Mercadante provided a better interpretation of data regarding the opioid swi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Haiying, Song, Yu, Xin, Wenxiu, Sun, Jiao, Zhong, Like, Zhou, Qinfei, He, Chaoneng, Gong, Liyan, Fang, Luo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Matters Arising
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10245518/
https://www.ncbi.nlm.nih.gov/pubmed/37280625
http://dx.doi.org/10.1186/s12904-023-01162-z
Descripción
Sumario:In our article ?Methadone switching for refractory cancer pain’ (BMC palliative care, 2022) we explore the efficacy, safety and economics of methadone in treatment of patients with refractory cancer pain in China. Professor Mercadante provided a better interpretation of data regarding the opioid switching to methadone in the Matters Arising. In this article, we answered the questions in Mercadante et al.’s comments one by one.

Ejemplares similares